| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.36 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |